On May 5, 2011
The Upside of Armageddon: As Lipitor’s End Approaches, Pfizer’s Rivals Are a Shambles
The winner of the right to make the first cheap generic competitor to Lipitor is Ranbaxy, the Indian company that cannot walk and chew gum at the same time.
No tags for this post.
0 Comments